Jouan-Lanhouet, S <br/><br/>
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.  [electronic resource] 

 -  Cell death and differentiation  Dec 2012 
 - 2003-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5403 
<br/><br/><label>Standard No.: </label>10.1038/cdd.2012.90  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--metabolism<br/>Animals<br/>Apoptosis--drug effects<br/>Cell Line<br/>Disease Models, Animal<br/>HT29 Cells<br/>Hep G2 Cells<br/>Hepatocytes--drug effects<br/>Humans<br/>Hydrogen-Ion Concentration<br/>Imidazoles--pharmacology<br/>Indoles--pharmacology<br/>Killer Cells, Natural--drug effects<br/>Mice<br/>Phenanthrenes--pharmacology<br/>Poly(ADP-ribose) Polymerase Inhibitors<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>RNA Interference<br/>RNA, Small Interfering--metabolism<br/>Reactive Oxygen Species--metabolism<br/>Receptor-Interacting Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>TNF-Related Apoptosis-Inducing Ligand--pharmacology